Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: Dr Stelfox and colleagues1 found that patients with methicillin-resistant Staphylococcus aureus (MRSA) who were isolated for infection
control experienced more preventable adverse events, expressed greater dissatisfaction
with their treatment, and had less documented care. I have several concerns
about the validity of this retrospective case-control study.
Parienti J. Quality of Care and Satisfaction Among Patients Isolated for Infection Control. JAMA. 2004;291(4):420-422. doi:10.1001/jama.291.4.420-a